Browse
Submit Data
Databases
API
Help

Dataset Information

7 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Outcomes of Perforation After Colorectal Endoscopic Submucosal Dissection

ABSTRACT: Endoscopic resection of superficial colorectal neoplasms decrease risk of colorectal cancer. En bloc resection is necessary for large superficial lesions with risk of superficial submucosal cancer and is advised if feasible for all lesions. Endoscopic submucosal dissection (ESD) allows en bloc resection of large superficial colorectal neoplasms, increasing curative resection rate and decreasing local recurrence risk. However, the risk of perprocedural or delayed perforation is higher compared to wild field piece meal endoscopic mucosal resection. Endoscoping clipping and closing methods mostly allow conservative treatment, but some case still necessitate surgery. The aim of our study is to describe and ananalyse outcomes after perprocedural or delayed perforation in all patients undergoing ESD and analyse the need for surgical intervention.

DISEASE(S): Perforation Colon,Colorectal Neoplasms,Perforation Of Rectum

PROVIDER: 8389 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Endoscopic Submucosal Dissection Versus Laparoscopic Resection for Early Colorectal Neoplasms

Project description:This is a prospective randomized trial that aimed to compare the short-term clinical outcomes and systemic inflammatory/cytokine responses of endoscopic submucosal dissection versus laparoscopic resection for early colorectal neoplasms that are not amenable to en bloc endoscopic resection with conventional techniques.

| 2088243 | ecrin-mdr-crc

Application of endoscopic submucosal tunnel dissection in the early esophagus, stomach and colorectal cancer

Project description:Interventions: experimental group :endoscopic submucosal tunnel dissection ;control group:Non-endoscopic submucosal tunnel dissection Primary outcome(s): En bloc resection;R0 resection rate;Curative resection rate;Dissection speed Study Design: Non randomized control

| 2669339 | ecrin-mdr-crc

To investigate the standard programme of endoscopic submucosal tunnelling (ESDTT) and conventional endoscopic submucosal dissection (ESD) for the treatment of early esophagus, stomach, colorectal cancer and precancerous lesions

Project description:Interventions: Group 1:endoscopic submucosal tunnel dissection;Group 2:Routine endoscopic submucosal dissection Primary outcome(s): En bloc dissection;R0 resection rate;curative resection rate;Dissection speed Study Design: Non randomized control

| 2669338 | ecrin-mdr-crc

Prospective, Consecutive, Single-Center Study Western (Greek) Single-Center Experience of Endoscopic Submucosal Dissection (ESD) for Early Gastrointestinal Neoplasia. That is really possible in a Greek General Hospital.

Project description:Interventions: Endoscopic submucosal dissection (ESD) Primary outcome(s): Endoscopic ’en bloc’ and complete pathological R0 resection. Study Design: Single arm Non-randomized

| 2624630 | ecrin-mdr-crc

Resection of esophageal, gastric, duodenal and colorectal neoplasias by ESD – Learning curve in a prevalence-based unsupervised western setting: a retrospective, multicentric trial

Project description:Interventions: Group 1: Resection in ESD technique (Endoscopic submucosal dissection) Primary outcome(s): rate of en bloc resection, rate of R0 resection, resection speed Study Design: Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: treatment

| 2439022 | ecrin-mdr-crc

Endoscopic Sub-mucosal Dissection With the Nestis Jet Injector System With a Bi-functional Catheter: First Prospective Trial

Project description:ESD (Endoscopic Sub-mucosal Dissection)is the first-intent method to treat superficial neoplasms of the digestive tract at it allows an en-bloc R0 resection. Following marking of the lesion margins, ESD comprises 3 steps: 1) liquid injection into the sub-mucosal space 2) circumferential (complete or partial) incision and 3) dissection of the submucosa. Several tools are necessary to perform ESD with the standard technique. Development of water jet with bi functional (injection and cutting) catheter allows time and significant reduction of perforation risk (due to multiple changes of instruments). For this purpose, Nestis introduced the Enki 2 pulsed jet technology with high pressure system to inject efficiently and at any time viscous solutions in direct viewing and retroflexion. Preliminary pig studies indicate that injection of glycerol, hyaluronate and hydroxyethlstarch with Enki 2 are possible. In addition, preclinical studies on living pig colon models using saline solutions have demonstrated that perforation rates and operating times are significantly reduced compared to a standard electrosurgical knife. The present clinical study is being performed to confirm this system capability to perform ESD in humans.

| 2149365 | ecrin-mdr-crc

Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions

Project description:To evaluate clinical outcome for patients receiving treatment of suspected premalignant and malignant gastrointestinal lesions at Interventional Endoscopy Services. The primary outcome is curative endoscopic resection. Secondary outcomes include resection technique utilized, rates of en bloc resection and adverse event rates, including infection, bleeding, perforation and death, and one-year survival rates.

| 2136933 | ecrin-mdr-crc

Brief Title : Optimized Endoscopic Submucosal Dissection With Snaring for Colorectal Neoplasm

Project description:This study is aimed to analyze the outcomes after conventional endoscopic submucosal dissection (ESD) and optimized ESD with snaring (oESD-S) for colorectal neoplasm that is more than 20 mm in diameter of laterllay spreading tumor or flat elevated lesion without stalk. Optimized ESD with snaring means submucosal dissection followed by snaring when narrowed circumference of the remained submucosal tissue beneath the lesion is less than 5 mm in diameter with snaring, then resected by using an electric current. The investigators expect optimized ESD with snaring can provide more time-saving procedure with comparable en-bloc resection rate and perforation rate, when compared with the conventional ESD method.

| 2151761 | ecrin-mdr-crc

Endoscopic submucosal dissection for treatment of advanced colorectal neoplasia

Project description:Interventions: Group 1: Patients to be included will have flat or sessile colorectal neoplasia > 20mm amenable to endoscopic treatment. Endoscopic resection will be done with endoscopic submucosal dissection rather than by piecemeal mucosectomy. Primary outcome(s): en bloc an R0 resection rate, evaluated endoscopically and by histopathology Study Design: Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: treatment

| 2439716 | ecrin-mdr-crc

Affymetrix SNP array data for esophageal squamous cell carcinoma samples

Project description:A proportion of superficial esophageal squamous cell carcinoma, a type of less invasive esophageal squamous cell carcinoma (ESCC), would have metastasis after esophagectomy or endoscopic resection with poor prognosis. The purpose of this study was to discover the whole-genome copy number alteration (CNA) profiles of superficial ESCC and compare the CNAs of superficial ESCC patients with and without metastasis after surgery. Thirty eight superficial ESCC cases, including 19 cases with metastasis and 19 cases without metastasis within 5 years after surgery, were analyzed CNAs by Affymetrix OncoScan™ FFPE Assay. A 39-gene signature was initially constructed to identify high risk of metastasis in superficial ESCC patients. In addition, amplification of 11q13.3 (FGF4) and deletion of 9p21.3 (CDKN2A) were identified as recurrent CNAs across all 38 superficial ESCC cases. And amplifications of 3p26.33 (SOX2-OT), 8q24.21 (MYC), 14q21.1 (FOXA1) and deletion of 3p12.1 (GBE1) were identified as recurrent CNAs among metastasis cases only. Our study provided a 39-gene signature tool to identified high risk metastasis in superficial ESCC and suggested that amplifications of SOX2-OT, MYC, FOXA1 genes and deletion of GBE1 gene might play a vital role in metastasis among superficial ESCC.

2017-06-10 | GSE78926 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data